A phase I, open-label study of intravenous human dental pulp stem cells (NestaCell®) at two dose levels in patients with Huntington’s disease - Joyce Macedo Sanches Fernandes; Eduardo Pagani; Cristiane Valverde Wenceslau; Leandro Hideki Ynoue; Luciana Ferrara; Irina Kerkis (Stem Cell Research & Therapy, 2025)